INTEROIL EXPL PROD And GYLDENDAL On The List Of Winners And Losers Of Friday’s Euronext Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are INTEROIL EXPL PROD, VIVORYON, and JINHUI SHIPP TRANS.

Financial Asset Price Change Updated (EST)
INTEROIL EXPL PROD (IOX.OL) 4.28 118.39% 2024-05-31 12:40:36
VIVORYON (VVY.AS) 2.48 23.69% 2024-05-31 12:04:41
JINHUI SHIPP TRANS (JIN.OL) 7.46 13.03% 2024-05-31 12:40:50
VOW (VOW.OL) 7.04 11.22% 2024-05-31 12:44:37
HYDROGENPRO (HYPRO.OL) 12.00 10.5% 2024-05-31 12:40:29
POLIGHT (PLT.OL) 2.74 9.2% 2024-05-31 12:42:41
NEL (NEL.OL) 7.67 9.14% 2024-05-31 12:41:32
ELECTROMAGNET GEO (EMGS.OL) 2.53 7.66% 2024-05-31 12:25:43
NYKODE THERAPEUTIC (NYKD.OL) 15.65 7.63% 2024-05-31 12:42:03
VALUE8 CUM PREF (PREVA.AS) 4.96 6.9% 2024-05-31 12:04:33

The three biggest losers today are GYLDENDAL, ATLANTIC SAPPHIRE, and PCI BIOTECH HOLD.

Financial Asset Price Change Updated (EST)
GYLDENDAL (GYL.OL) 460.00 -8% 2024-05-31 12:40:20
ATLANTIC SAPPHIRE (ASA.OL) 11.27 -6.08% 2024-05-31 12:24:43
PCI BIOTECH HOLD (PCIB.OL) 1.94 -5.37% 2024-05-31 12:42:27
CABKA (CABKA.AS) 4.60 -4.96% 2024-05-31 12:01:08
DIEGEM KENNEDYCERT (DIEG.BR) 114.00 -4.2% 2024-05-31 12:06:34
EQVA (EQVA.OL) 5.02 -4.2% 2024-05-31 12:26:00
OCEANTEAM (OTS.OL) 1.11 -3.91% 2024-05-31 12:42:05
ARRIBATEC GROUP (ARR.OL) 3.51 -3.84% 2024-05-31 12:24:37
HAVILA SHIPPING (HAVI.OL) 5.39 -3.75% 2024-05-31 12:40:23
ZAPTEC (ZAP.OL) 13.69 -3.52% 2024-05-31 12:44:55

Winners today

1. INTEROIL EXPL PROD (IOX.OL)

118.39% Price Change

Interoil Exploration and Production ASA, together with its subsidiaries, operates as an upstream oil exploration and production company. It engages in the acquisition, exploration, development, and operation of oil and natural gas properties. The company's portfolio includes two producing concessions and two exploration concessions in Colombia; and one exploration and seven production concessions in Argentina. Interoil Exploration and Production ASA was incorporated in 2005 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with INTEROIL EXPL PROD jumping 118.39% to €4.28 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.87% to €1,440.53, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, INTEROIL EXPL PROD has a trailing twelve months EPS of kr-1.05.

Moving Average

INTEROIL EXPL PROD’s worth is way higher than its 50-day moving average of kr2.47 and way under its 200-day moving average of kr5.00.

Revenue Growth

Year-on-year quarterly revenue growth grew by 94.4%, now sitting on 23.92M for the twelve trailing months.

Volume

Today’s last reported volume for INTEROIL EXPL PROD is 2627220 which is 8663.25% above its average volume of 29980.

Volatility

INTEROIL EXPL PROD’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.39%, a negative 0.07%, and a positive 2.50%.

INTEROIL EXPL PROD’s highest amplitude of average volatility was 2.26% (last week), 2.12% (last month), and 2.50% (last quarter).

More news about INTEROIL EXPL PROD.

2. VIVORYON (VVY.AS)

23.69% Price Change

Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.

AEX-Index ended the session with VIVORYON jumping 23.69% to €2.48 on Friday, after three successive sessions in a row of losses. AEX-Index fell 0.22% to €903.61, after three consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, VIVORYON has a trailing twelve months EPS of €-1.12.

More news about VIVORYON.

3. JINHUI SHIPP TRANS (JIN.OL)

13.03% Price Change

Jinhui Shipping and Transportation Limited, an investment holding company, engages in ship chartering and owning activities internationally. The company engages in money lending; property investment activities; and management and shipping agent services. It also owns a fleet of twenty three grabs fitted supramaxes and one chartered-in-panamax with carrying capacity of approximately 1,415,930 metric tons. The company was founded in 1987 and is based in Hong Kong, Hong Kong. Jinhui Shipping and Transportation Limited operates as a subsidiary of Jinhui Holdings Company Limited.

Oslo Børs Benchmark Index_GI ended the session with JINHUI SHIPP TRANS jumping 13.03% to €7.46 on Friday, after two consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.87% to €1,440.53, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, JINHUI SHIPP TRANS has a trailing twelve months EPS of kr-5.3.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -14.47%.

Volume

Today’s last reported volume for JINHUI SHIPP TRANS is 515081 which is 734.61% above its average volume of 61715.

More news about JINHUI SHIPP TRANS.

4. VOW (VOW.OL)

11.22% Price Change

Vow ASA, together with its subsidiaries, produces, delivers, and maintains systems for processing and purifying wastewater, food waste, solid waste, and bio sludge in Norway, France, Poland, the United States, and Italy. The company operates through Industrial Solutions, Maritime Solutions, and Aftersales segments. The Industrial Solutions segment offers and designs plants for processing biomass, food products, and industry residues. The Maritime Solution segment delivers ship systems to shipyards for newbuild constructions, which include advanced wastewater purification, waste management, and food waste processing; and advanced systems to shipowners for ships. The Aftersales segment provides spare parts and consumables chemicals; and tailor-made service and maintenance programs. In addition, it offers Biogreen, a patented pyrolysis process for converting biomass, plastics, and waste into energy; Safesteril, a patented sterilisation process for food and pharmaceutical ingredients; and industrial robotics solutions, including robotic systems for waste recycling processes. Further, the company develops, designs, and fabricates industrial furnaces and equipment for heat treatment processes. It serves cruise, aquaculture, and landbased industries, as well as utilities. The company has a strategic partnership agreement with Repsol, S.A. for addressing the pressing issue of plastic waste; SAS IMPROVE for research and development of technological solutions; and Circon Energy, for equipment supply carbon refinery projects. The company was formerly known as Scanship Holding ASA and changed its name to VOW ASA in January 2020. Vow ASA was founded in 2011 and is headquartered in Lysaker, Norway.

Oslo Børs Benchmark Index_GI ended the session with VOW jumping 11.22% to €7.04 on Friday while Oslo Børs Benchmark Index_GI rose 0.87% to €1,440.53.

Earnings Per Share

As for profitability, VOW has a trailing twelve months EPS of kr-1.34.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -33.1%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 22.7%, now sitting on 918.5M for the twelve trailing months.

Volatility

VOW’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.86%, a negative 0.16%, and a positive 4.12%.

VOW’s highest amplitude of average volatility was 1.84% (last week), 4.19% (last month), and 4.12% (last quarter).

More news about VOW.

5. HYDROGENPRO (HYPRO.OL)

10.5% Price Change

HydrogenPro ASA engages in designing and delivering hydrogen technology and systems in Norway, Europe, the United States, and the Asia Pacific. It offers high-pressure alkaline electrolyzers. The company serves synthetic aviation fuel, refinery/decarbonization, power to gas, balancing the grid, steel production, fertilizer/ammonia, and shipping markets. HydrogenPro ASA was incorporated in 2013 and is headquartered in Porsgrunn, Norway.

Oslo Børs Benchmark Index_GI ended the session with HYDROGENPRO rising 10.5% to €12.00 on Friday while Oslo Børs Benchmark Index_GI rose 0.87% to €1,440.53.

Earnings Per Share

As for profitability, HYDROGENPRO has a trailing twelve months EPS of kr-1.48.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.59%.

Volatility

HYDROGENPRO’s last week, last month’s, and last quarter’s current intraday variation average was a positive 2.12%, a negative 1.14%, and a positive 4.23%.

HYDROGENPRO’s highest amplitude of average volatility was 2.12% (last week), 4.21% (last month), and 4.23% (last quarter).

More news about HYDROGENPRO.

6. POLIGHT (PLT.OL)

9.2% Price Change

poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; driver ASIC is designed to drive capacitive loads such as the TLens autofocus actuators; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. It serves smartphones and wearables, industrial, augmented reality, healthcare, and webcams markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.

Oslo Børs Benchmark Index_GI ended the session with POLIGHT rising 9.2% to €2.74 on Friday while Oslo Børs Benchmark Index_GI jumped 0.87% to €1,440.53.

Earnings Per Share

As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.19.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.82%.

Moving Average

POLIGHT’s worth is way under its 50-day moving average of kr3.30 and way under its 200-day moving average of kr11.58.

Yearly Top and Bottom Value

POLIGHT’s stock is valued at kr2.74 at 22:40 EST, way under its 52-week high of kr25.70 and way above its 52-week low of kr2.34.

Revenue Growth

Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 22.51M for the twelve trailing months.

More news about POLIGHT.

7. NEL (NEL.OL)

9.14% Price Change

Nel ASA, a hydrogen company, provides various solutions to produce, store, and distribute hydrogen from renewable energy in Norway and internationally. The company operates in two segments, Nel Hydrogen Fueling and Nel Hydrogen Electrolyser. The Nel Hydrogen Fueling segment manufactures hydrogen fueling stations for fuel cell electric vehicles, such as cars, buses, trucks, and other on-road vehicles. The Nel Hydrogen Electrolyser segment supplies hydrogen production equipment based on alkaline and proton exchange membrane water electrolysis technology. It serves industries, energy, and gas companies. The company was formerly known as DiaGenic ASA and changed its name to Nel ASA in October 2014. Nel ASA was founded in 1927 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NEL rising 9.14% to €7.67 on Friday while Oslo Børs Benchmark Index_GI rose 0.87% to €1,440.53.

Earnings Per Share

As for profitability, NEL has a trailing twelve months EPS of kr-0.41.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.47%.

More news about NEL.

8. ELECTROMAGNET GEO (EMGS.OL)

7.66% Price Change

Electromagnetic Geoservices ASA, together with its subsidiaries, provides electromagnetic (EM) surveying services to the offshore oil and gas exploration industry. It is involved in the planning, acquisition, processing, modelling, interpretation, and integration of EM data. The company uses its patented EM survey method to find hydrocarbons in offshore reservoirs. It engages in the provision of controlled-source EM surveying and magneto telluric surveying; imaging and interpretation; rental of software and cluster; and training services. The company has operations in Europe, the Middle East, Africa, Norway, North and South America, Asia, and the Pacific Ocean. Electromagnetic Geoservices ASA was incorporated in 2002 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ELECTROMAGNET GEO jumping 7.66% to €2.53 on Friday, after two successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.87% to €1,440.53, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, ELECTROMAGNET GEO has a trailing twelve months EPS of kr-0.98.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 145.52%.

More news about ELECTROMAGNET GEO.

9. NYKODE THERAPEUTIC (NYKD.OL)

7.63% Price Change

Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for T cell vaccine development; and research agreement with Regeneron. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NYKODE THERAPEUTIC rising 7.63% to €15.65 on Friday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.87% to €1,440.53, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, NYKODE THERAPEUTIC has a trailing twelve months EPS of kr-1.37.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.42%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 36.2%, now sitting on 13.32M for the twelve trailing months.

Yearly Top and Bottom Value

NYKODE THERAPEUTIC’s stock is valued at kr15.65 at 22:40 EST, way under its 52-week high of kr30.86 and way above its 52-week low of kr12.38.

More news about NYKODE THERAPEUTIC.

10. VALUE8 CUM PREF (PREVA.AS)

6.9% Price Change

Value8 N.V. is a private equity firm specializing in growth capital investments in small and medium-sized companies. The firm primarily invests in the food, healthcare, business and financial services, energy, safety and security, water and environment, leisure, luxury products and internet sectors. It typically invests in Western Europe, primarily in the Netherlands, Belgium and France. The firm considers investments in companies with an enterprise value between €5 million ($6.96 million) and €150 million ($208.87 million). The firm prefers to take a seat on the board of directors and seeks to exit the investment through a public listing. Value8 NV was founded in 2008 and is headquartered in Bussum, the Netherlands.

AEX-Index ended the session with VALUE8 CUM PREF rising 6.9% to €4.96 on Friday, following the last session’s upward trend. AEX-Index slid 0.22% to €903.61, after three successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, VALUE8 CUM PREF has a trailing twelve months EPS of €1.869.

PE Ratio

VALUE8 CUM PREF has a trailing twelve months price to earnings ratio of 2.65. Meaning, the purchaser of the share is investing €2.65 for every euro of annual earnings.

More news about VALUE8 CUM PREF.

Losers Today

1. GYLDENDAL (GYL.OL)

-8% Price Change

Gyldendal ASA, through its subsidiaries, publishes and sells books in Norway. The company also publishes and produces content, including learning materials for kindergarten, primary school, upper secondary school, students, and professional market; and sells audiobooks and other goods, as well as provides streaming services. It operates bookstores and an online bookstore. The company was founded in 1925 and is headquartered in Oslo, Norway. Gyldendal ASA operates as a subsidiary of Erik Must AS.

Oslo Børs Benchmark Index_GI ended the session with GYLDENDAL falling 8% to €460.00 on Friday, after five sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.87% to €1,440.53, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, GYLDENDAL has a trailing twelve months EPS of kr-16.65.

Volume

Today’s last reported volume for GYLDENDAL is 72 which is 928.57% above its average volume of 7.

More news about GYLDENDAL.

2. ATLANTIC SAPPHIRE (ASA.OL)

-6.08% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the production and sale of land-based salmon in Denmark and the United States. The company was incorporated in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE dropping 6.08% to €11.27 on Friday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.87% to €1,440.53, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-36.83.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

More news about ATLANTIC SAPPHIRE.

3. PCI BIOTECH HOLD (PCIB.OL)

-5.37% Price Change

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD dropping 5.37% to €1.94 on Friday while Oslo Børs Benchmark Index_GI jumped 0.87% to €1,440.53.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.54.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.

More news about PCI BIOTECH HOLD.

4. CABKA (CABKA.AS)

-4.96% Price Change

Cabka N.V. manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally. The company also offers services, including customized solutions; track and trace; and life cycle and carbon footprint analysis. It sells its recycled plastic products to the agriculture, food and beverage, retail, automotive, chemical, pharmaceutical, and pooling industries. The company was incorporated in 1994 and is headquartered in Berlin, Germany.

AEX-Index ended the session with CABKA dropping 4.96% to €4.60 on Friday, after two consecutive sessions in a row of gains. AEX-Index slid 0.22% to €903.61, after three consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, CABKA has a trailing twelve months EPS of €-0.06.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.15%.

Sales Growth

CABKA’s sales growth for the current quarter is 4.8%.

Volatility

CABKA’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.16%, a negative 0.21%, and a positive 2.83%.

CABKA’s highest amplitude of average volatility was 4.51% (last week), 2.12% (last month), and 2.83% (last quarter).

Volume

Today’s last reported volume for CABKA is 4721 which is 12.29% above its average volume of 4204.

Moving Average

CABKA’s worth is way below its 50-day moving average of €5.12 and way below its 200-day moving average of €6.39.

More news about CABKA.

5. DIEGEM KENNEDYCERT (DIEG.BR)

-4.2% Price Change

Immolease Trust NV operates as a subsidiary of KBC Bank NV.

BEL 20 ended the session with DIEGEM KENNEDYCERT dropping 4.2% to €114.00 on Friday while BEL 20 jumped 0.24% to €3,918.09.

More news about DIEGEM KENNEDYCERT.

6. EQVA (EQVA.OL)

-4.2% Price Change

Eqva ASA, provides technical solutions and services to maritime and land based industries in Norway and internationally. It operates in three segments: Products, Solutions & Renewables; Real Estate; and Other. The company provides technical installations to the land-based and maritime industry; and develops and operates small-scale hydropower plants. It also engages in real estate business. The company was formerly known as Havyard Group ASA and changed its name to Eqva ASA in November 2022. Eqva ASA was incorporated in 1999 and is headquartered in Kvinnherad, Norway.

Oslo Børs Benchmark Index_GI ended the session with EQVA dropping 4.2% to €5.02 on Friday, after four consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.87% to €1,440.53, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, EQVA has a trailing twelve months EPS of kr0.23.

PE Ratio

EQVA has a trailing twelve months price to earnings ratio of 21.83. Meaning, the purchaser of the share is investing kr21.83 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.45%.

More news about EQVA.

7. OCEANTEAM (OTS.OL)

-3.91% Price Change

Oceanteam ASA does not have significant operations. Previously, it engaged in a subsea and offshore business. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Baerum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM falling 3.91% to €1.11 on Friday while Oslo Børs Benchmark Index_GI rose 0.87% to €1,440.53.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.23.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.79%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, OCEANTEAM’s stock is considered to be overbought (>=80).

Moving Average

OCEANTEAM’s value is below its 50-day moving average of kr1.17 and way under its 200-day moving average of kr1.40.

Revenue Growth

Year-on-year quarterly revenue growth declined by 33.3%, now sitting on 60k for the twelve trailing months.

More news about OCEANTEAM.

8. ARRIBATEC GROUP (ARR.OL)

-3.84% Price Change

Arribatec Group ASA, a software and consulting company, provides digital business solutions in Norway, Europe, the Americas, and internationally. The company offers solutions for businesses, including ERP systems, integrations, consulting, health checks, develops, HR and payroll, financial and project planning, bank solutions, and travel and expenses. Its solutions include QualiWare, a management system that structures and visualizes processes, activities, regulations, and requirements; Unit4 solutions; RamBase, an ERP business solution that gives control over the value chain; Power BI solutions; Hypergene, a business management tool; Adra Suite that integrates with other financial systems; Microsoft 365; CatalystOne; and Pagero that ensures compliance with legal and electronic billing requirements. Arribatec Group ASA was incorporated in 1998 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ARRIBATEC GROUP falling 3.84% to €3.51 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.87% to €1,440.53, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, ARRIBATEC GROUP has a trailing twelve months EPS of kr-0.37.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.94%.

Moving Average

ARRIBATEC GROUP’s worth is way below its 50-day moving average of kr5.92 and under its 200-day moving average of kr3.71.

Volatility

ARRIBATEC GROUP’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.41%, a negative 0.17%, and a positive 2.31%.

ARRIBATEC GROUP’s highest amplitude of average volatility was 2.37% (last week), 2.82% (last month), and 2.31% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 23.2%, now sitting on 557M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ARRIBATEC GROUP’s EBITDA is 48.44.

More news about ARRIBATEC GROUP.

9. HAVILA SHIPPING (HAVI.OL)

-3.75% Price Change

Havila Shipping ASA, together with its subsidiaries, engages in the shipping business. It manages and operates offshore service vessels primarily in Norway, the United Kingdom, Denmark, Belgium, the Netherlands, Iceland, Tunisia, the Marshall Islands, and the United States. The company operates a fleet of vessels, including anchor handling vessels, platform supply vessels, rescue recovery vessel, and subsea vessels. Its subsea vessels are used for under water construction work, as well as for support for under water operations; and rescue recovery vessels are used to offer security services, such as oil spill preparedness, fire protection, rescue operation, and recovery at oil installations. In addition, the company offers renewable energy services comprising of cable repair, trenching and ploughing, mooring and towing, and daughter craft operations, and transport of equipment and good services. The company was founded in 2003 and is headquartered in Fosnavåg, Norway. Havila Shipping ASA is a subsidiary of Havila Holding AS.

Oslo Børs Benchmark Index_GI ended the session with HAVILA SHIPPING dropping 3.75% to €5.39 on Friday while Oslo Børs Benchmark Index_GI jumped 0.87% to €1,440.53.

Earnings Per Share

As for profitability, HAVILA SHIPPING has a trailing twelve months EPS of kr-0.22.

More news about HAVILA SHIPPING.

10. ZAPTEC (ZAP.OL)

-3.52% Price Change

Zaptec ASA engages in the development and sale of chargers, charging systems, and services for electric car charging in Norway, Sweden, Switzerland, Denmark, Iceland, rest of Europe, and internationally. It offers Zaptec Go and Zaptec Pro alternating current walls charging station for indoor and outdoor use; Zaptec Portal, a cloud platform that monitors, balances, and optimizes the load between charging stations, while displaying real-time power usage; and Zaptec Sense for automatically adjusting the charging speed in the buildings. The company also offers accessories, including covers, charging cables, cable holders, RFID tags, and load balancers. Zaptec ASA was incorporated in 2012 and is headquartered in Stavanger, Norway.

Oslo Børs Benchmark Index_GI ended the session with ZAPTEC sliding 3.52% to €13.69 on Friday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.87% to €1,440.53, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, ZAPTEC has a trailing twelve months EPS of kr0.22.

PE Ratio

ZAPTEC has a trailing twelve months price to earnings ratio of 62.23. Meaning, the purchaser of the share is investing kr62.23 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.37%.

Yearly Top and Bottom Value

ZAPTEC’s stock is valued at kr13.69 at 22:40 EST, way under its 52-week low of kr15.66.

More news about ZAPTEC.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *